Sensorium Therapeutics
Sensorium Therapeutics is a startup headquartered in Medford, United States, founded in 2021. It has raised at least $26.8m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
Sensorium Therapeutics has raised at least $26.8m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
Sensorium Therapeutics sits inside the Boston and New England R&D ecosystem in the Global R&D Labs Directory.
Other startups in Medford
Related
- Innovation profile of Medford
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Sensorium Therapeutics do?
Sensorium Therapeutics is classed in pharmaceuticals in its filings with the US Securities and Exchange Commission.
How much has Sensorium Therapeutics raised?
At least $26.8m, according to its Form D filings with the US Securities and Exchange Commission.
Where is Sensorium Therapeutics based?
Sensorium Therapeutics is headquartered in Medford, United States.
When was Sensorium Therapeutics founded?
Sensorium Therapeutics was founded in 2021.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.